Isoxsuprine%2525252525252525252520hydrochloride

# Isoxsuprine Hydrochloride ## Overview Isoxsuprine hydrochloride is a vasodilator. Its exact mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle and potentially beta-adrenergic stimulation. ## Primary Indications * Treatment of peripheral vascular disease (e.g., arteriosclerosis obliterans, intermittent claudication, Buerger's disease) to improve blood supply to the limbs. * Historically used for threatened premature labor, but this is generally not recommended due to lack of efficacy and potential maternal risks. ## Adult Dosing * **Peripheral Vascular Disease:** 10 mg to 20 mg orally three to four times daily. * **Maximum Dose:** Not clearly defined for peripheral vascular disease, but doses exceeding 20 mg per administration or 80 mg per day are generally not recommended. ## Pediatric Dosing There is no established pediatric dosing for isoxsuprine hydrochloride. Its use in children is generally not recommended. ## Dose Adjustments No specific dose adjustments are routinely recommended for renal or hepatic impairment. However, caution and close monitoring are advised in patients with compromised organ function due to potential for systemic effects. ## Contraindications * Hypersensitivity to isoxsuprine hydrochloride. * Use in patients who have experienced a recent cardiovascular event (e.g., myocardial infarction). * Use in patients with certain cardiac arrhythmias. * Avoid use in pregnancy for threatened premature labor due to lack of efficacy and potential risks. ## Adverse Effects * **Cardiovascular:** Hypotension, dizziness, lightheadedness, flushing, tachycardia, arrhythmias. * **Gastrointestinal:** Nausea, vomiting, abdominal distress, heartburn. * **Other:** Weakness, nervousness, drowsiness, rash. ## Key Drug Interactions * **Antihypertensives:** May potentiate the hypotensive effects of antihypertensive medications. * **Vasodilators:** Additive hypotensive effects. ## Monitoring * Blood pressure and heart rate. * Signs and symptoms of peripheral vascular disease improvement (e.g., pain, cramping, skin temperature, color). * Adverse effects, particularly cardiovascular. ## Clinical Pearls * Isoxsuprine has shown limited efficacy in many clinical trials for peripheral vascular disease, and its use is less common now compared to other therapeutic options. * Patients should be advised to stand or sit up slowly when rising from a sitting or lying position to minimize dizziness and potential falls. * Effectiveness is best evaluated over a period of several months. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and product literature, and exercise professional judgment before making therapeutic decisions. Dosing and indications may vary based on individual patient factors, local protocols, and updated clinical guidelines.